The United States Food and Drug Administration (FDA) has approved Poteligeo (mogamulizumab-kpkc) for the treatment of two types of rare…
The United States Food and Drug Administration (FDA) has approved Poteligeo (mogamulizumab-kpkc) for the treatment of two types of rare…